Intuitive Surgical is a pioneering medical device company specializing in robotic-assisted surgical systems, most notably the da Vinci Surgical System. This innovative platform enhances the precision and control of minimally invasive surgical procedures, enabling surgeons to perform operations with greater accuracy and reduced recovery times for patients. The company is dedicated to advancing the field of robotics in surgery, providing training and support for healthcare professionals, and continually innovating its technology to improve patient outcomes across various medical specialties. Read More
A number of stocks fell in the afternoon session after markets continued to decline, as investors grew cautious ahead of a key speech by Federal Reserve Chair Jerome Powell. The move came as U.S. equity markets recorded a fifth consecutive day of losses for major indexes like the S&P 500, with technology stocks experiencing the largest declines. Investors have grown wary that the sharp rally in the tech sector since April may have advanced too far. The market-wide caution is largely driven by the upcoming Jackson Hole symposium, a meeting of central bankers, where traders are anxiously awaiting Fed Chair Powell's speech on Friday for guidance on the future path of interest rates.
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages.
Just because a business is in the green today doesn’t mean it will thrive tomorrow.
Over the last six months, Intuitive Surgical’s shares have sunk to $480, producing a disappointing 18.9% loss - a stark contrast to the S&P 500’s 6.4% gain. This may have investors wondering how to approach the situation.
Growth is oxygen.
But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble or newer investors who lived through the 2020 to 2022 COVID cycle.
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at surgical equipment & consumables - specialty stocks, starting with Intuitive Surgical (NASDAQ:ISRG).
The stock market is currently experiencing a profound transformation, driven by the relentless rise of Artificial Intelligence (AI). This technological revolution is not merely a fleeting trend but a fundamental shift, propelling unprecedented growth within the tech sector and attracting colossal investments from industry titans. The immediate implications are clear:
The U.S. and Japan announced a big trade deal that lowers tariffs to just 15% on imports, and the team discusses earnings from General Motors, Intuitive Surgical, and Enphase Energy.
The Nasdaq 100 (^NDX) is known for housing some of the most innovative and fastest-growing companies in the market.
But not every stock in the index is a winner - some are struggling with slowing growth, increasing competition, or unsustainable valuations.
Medical technology company Intuitive Surgical (NASDAQ:ISRG) reported Q2 CY2025 results topping the market’s revenue expectations, with sales up 21.4% year on year to $2.44 billion. Its non-GAAP profit of $2.19 per share was 14.2% above analysts’ consensus estimates.
Robotics healthcare giant Intuitive Surgical handily beat expectations in Q2. Shares stayed flat; the bullish long-term outlook for this stock rides on.
A wave of U.S. trade deals with key allies over the past 24 hours reignited Wall Street's rally and boosted investor risk appetite across global markets.
